Cell cycle and apoptosis.
暂无分享,去创建一个
[1] P. Auberger,et al. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest , 1999, Oncogene.
[2] W. Kaelin,et al. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. Muller,et al. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity , 1999, Oncogene.
[4] J. M. Lee,et al. p53 regulates a G2 checkpoint through cyclin B1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Shankland,et al. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). , 1999, The Journal of clinical investigation.
[6] A. Giordano,et al. Cell cycle and cancer. , 1999, La Clinica terapeutica.
[7] A. Berns,et al. A link between cell cycle and cell death: Bax and Bcl‐2 modulate Cdk2 activation during thymocyte apoptosis , 1998, The EMBO journal.
[8] M. Montenarh,et al. Regulation of CAK kinase activity by p53 , 1998, Oncogene.
[9] C. Sherr,et al. Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.
[10] Prem Seth,et al. Cleavage of CDK Inhibitor p21Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis* , 1998, The Journal of Biological Chemistry.
[11] K. Kurisu,et al. Adenovirus‐mediated p16 gene transfer prevents drug‐induced cell death through G1 arrest in human glioma cells , 1998 .
[12] V. Kidd,et al. Phosphorylation of PITSLRE p110 Isoforms Accompanies Their Processing by Caspases during Fas-mediated Cell Death* , 1998, The Journal of Biological Chemistry.
[13] K. Harvey,et al. Commitment and Effector Phases of the Physiological Cell Death Pathway Elucidated with Respect to Bcl-2, Caspase, and Cyclin-Dependent Kinase Activities , 1998, Molecular and Cellular Biology.
[14] M. Andreeff,et al. Accumulation of cyclin B1, activation of cyclin B1‐dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol , 1998, International journal of cancer.
[15] James M. Roberts,et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. , 1998, Molecular cell.
[16] N. Donato,et al. Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells* , 1998, The Journal of Biological Chemistry.
[17] T. Yagi,et al. Mutated p21WAF1/CIP1/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells , 1998, Oncogene.
[18] M. Kasten,et al. pRb and the Cdks in apoptosis and the cell cycle , 1998, Cell Death and Differentiation.
[19] M L Agarwal,et al. The p53 Network* , 1998, The Journal of Biological Chemistry.
[20] M. Gorospe,et al. p27Kip1 overexpression causes apoptotic death of mammalian cells , 1997, Oncogene.
[21] K. Kinzler,et al. 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .
[22] G. Cooper,et al. Identification of the MDM2 Oncoprotein as a Substrate for CPP32-like Apoptotic Proteases* , 1997, The Journal of Biological Chemistry.
[23] W. Fiers,et al. Cleavage of PITSLRE Kinases by ICE/CASP-1 and CPP32/CASP-3 during Apoptosis Induced by Tumor Necrosis Factor* , 1997, The Journal of Biological Chemistry.
[24] M. Barbacid,et al. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.
[25] Daniel E. Johnson,et al. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family , 1997, Journal of cellular biochemistry.
[26] G. Wahl,et al. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. , 1997, Cancer research.
[27] J. Bartek,et al. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death , 1997, Nature Medicine.
[28] P. Golstein. Controlling Cell Death , 1997, Science.
[29] M. Raff,et al. Programmed Cell Death in Animal Development , 1997, Cell.
[30] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[31] A. Porter,et al. Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis. , 1996, The EMBO journal.
[32] A. Porter,et al. Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis , 1996, Molecular and cellular biology.
[33] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[34] K. Kinzler,et al. Genetic determinants of p53-induced apoptosis and growth arrest. , 1996, Genes & development.
[35] K. Walsh,et al. Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation , 1996, Science.
[36] T. Jacks,et al. Targeted disruption of p107: functional overlap between p107 and Rb. , 1996, Genes & development.
[37] P. Dirks,et al. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. , 1996, Critical reviews in biochemistry and molecular biology.
[38] Y. Doki,et al. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[39] C. Harris,et al. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. , 1996, Genes & development.
[40] C. Steer,et al. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. , 1996, Oncogene.
[41] P. Fallon,et al. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. , 1996, Oncogene.
[42] A. Ross,et al. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells , 1996, Molecular and cellular biology.
[43] G. Woude,et al. Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.
[44] Q. Dou,et al. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. , 1996, Cancer research.
[45] S. Elledge,et al. Cdk inhibitors in development and cancer. , 1996, Current opinion in genetics & development.
[46] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[47] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[48] W. Deppert,et al. Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .
[49] G. Stark,et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Weintraub,et al. Mechanism of active transcriptional repression by the retinoblastoma protein , 1995, Nature.
[51] J. Roth,et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.
[52] J. Cidlowski,et al. Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.
[53] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[54] M. Israel,et al. Inhibition of apoptosis by the retinoblastoma gene product. , 1995, The EMBO journal.
[55] D. Campana,et al. Copyright � 1995, American Society for Microbiology PITSLRE Protein Kinase Activity Is Associated with Apoptosis , 1994 .
[56] E. Lam,et al. DP and E2F proteins: coordinating transcription with cell cycle progression. , 1994, Current opinion in cell biology.
[57] J. Butel,et al. The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice , 1994, Molecular and cellular biology.
[58] T. Jacks,et al. Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.
[59] E. White,et al. Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes , 1994, Journal of cellular physiology.
[60] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[61] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[62] Stephen S. Gisselbrecht,et al. Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[63] H. Symonds,et al. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.
[65] Yi-Song Wang,et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.
[66] G. Evan,et al. The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.
[67] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[68] N. Hay,et al. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.
[69] R. Weinberg,et al. Effects of an Rb mutation in the mouse , 1992, Nature.
[70] I. Krantz,et al. KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.
[71] D. Scott,et al. Role of c-myc and p27 in anti-IgM induced B-lymphoma apoptosis. , 1997, Current topics in microbiology and immunology.
[72] A. Giordano,et al. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. , 1995, Critical reviews in eukaryotic gene expression.
[73] G. Evan,et al. Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.
[74] D. Riley,et al. The retinoblastoma protein: more than a tumor suppressor. , 1994, Annual review of cell biology.
[75] Eric Wickstrom,et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.